This report contains market size and forecasts of Digital Companion Diagnostics in Global, including the following market information:
Global Digital Companion Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Digital Companion Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Polymerase Chain Reaction (PCR) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Digital Companion Diagnostics include Roche Holdings (Switzerland), Abbott Laboratories (US), Thermo Fisher Scientific (US), Agilent Technologies (US), Life Technologies (US), GE Healthcare (UK), Agendia (Angola), Qiagen (Germany) and Genomic Health (US), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Digital Companion Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Digital Companion Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Digital Companion Diagnostics Market Segment Percentages, by Type, 2021 (%)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Next Generation Sequencing (NGS)
Global Digital Companion Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Digital Companion Diagnostics Market Segment Percentages, by Application, 2021 (%)
Hospitals
Pharmaceutical Companies
Laboratories
Other
Global Digital Companion Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Digital Companion Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Digital Companion Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Digital Companion Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche Holdings (Switzerland)
Abbott Laboratories (US)
Thermo Fisher Scientific (US)
Agilent Technologies (US)
Life Technologies (US)
GE Healthcare (UK)
Agendia (Angola)
Qiagen (Germany)
Genomic Health (US)
Myriad Genetics (US)
Advanced Cell Diagnostics (US)
Danaher (US)
Applied Proteomics (US)